课题基金 / 基金详情

Probiotic Prawn Oral Immunotherapy (ProPIT) for Treatment of Prawn Allergy

Probiotic Prawn Oral Immunotherapy (ProPIT) for Treatment of Prawn Allergy
益生菌虾口服免疫疗法 (ProPIT) 用于治疗虾过敏
批准号:
nhmrc : 1144965
负责人:
Prof Andreas Lopata
金额:
$126.12万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 2022-12-31

项目摘要

项目成果

Prof Andreas Lopata的其他基金

相似基金

相关文献

中文摘要
翻译
为了防止死亡和改善护理,需要一种“根治性”的食物过敏治疗。我们最近发现益生菌花生口服免疫疗法(PPOIT)治疗花生过敏是非常有效的。82%的接受PPOIT治疗的儿童获得了耐受性,而安慰剂组的这一比例为4%。我们现在将测试益生菌-食物OIT联合治疗对虾过敏的方法。如果成功,我们将确定第一种对虾过敏疗法和一种治疗其他食物过敏的平台疗法。
英文摘要
A ‘curative’ food allergy treatment is needed to prevent deaths and improve care. We recently showed that probiotic peanut oral immunotherapy (PPOIT) was highly effective for treating peanut allergy. 82% of PPOIT treated children gained tolerance compared to 4% of the placebo group. We will now test the combined probiotic-food OIT approach for treating prawn allergy. If successful, we will have identified the first treatment for prawn allergy and a platform treatment for other food allergies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bio-molecular studies for improved diagnosis and management of Australian children with fish allergy
  • 批准号:
    nhmrc : 1086656
  • 项目类别:
    Project Grants
  • 资助金额:
    $33.11万
  • 财政年份:
    2015
  • 负责人:
    Prof Andreas Lopata
  • 依托单位:
Bio-molecular studies for improved diagnosis and management of Australian children with fish allergy
  • 批准号:
    nhmrc : GNT1086656
  • 项目类别:
    Project Grants
  • 资助金额:
    $47.68万
  • 财政年份:
    2015
  • 负责人:
    Prof Andreas Lopata
  • 依托单位:
Molecular and immunological approaches to managing Australia's seafood allergy epidemic
  • 批准号:
    FT110100635
  • 项目类别:
    ARC Future Fellowships
  • 资助金额:
    $47.86万
  • 财政年份:
    2012
  • 负责人:
    Prof Andreas Lopata
  • 依托单位:
海外基金